High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801
(Q73825066)
scientific article published on 01 May 2001
scientific article published on 01 May 2001
Language:
other details
description | scientific article published on 01 May 2001 |
External Links
(P356) |
10.1200/JCO.2001.19.9.2370
|
(P698) |
11331315
|